Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000131

Options or other derivatives

  • SVP, Specialty Commercial acquired 163,159 shares (grant or award)
  • SVP, Specialty Commercial returned 163,159 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Todisco Joseph SVP, Specialty Commercial 2019-11-13 Returned to the company · Stock Option −72,661 0 D: show line 1 in the form
Todisco Joseph SVP, Specialty Commercial 2019-11-13 Grant or award · Stock Option +72,661 72,661 D: show line 2 in the form
Todisco Joseph SVP, Specialty Commercial 2019-11-13 Returned to the company · Stock Option −90,498 0 D: show line 3 in the form
Todisco Joseph SVP, Specialty Commercial 2019-11-13 Grant or award · Stock Option +90,498 90,498 D: show line 4 in the form
Loading xslF345X03/wf-form4_157377043282006.xml…